NSHS — Nanosphere Health Sciences Income Statement
0.000.00%
Last trade - 00:00
- CA$0.21m
- CA$0.19m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.038 | 0.218 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.09 | 2.62 | 0.591 | 0.356 | 0.282 |
Operating Profit | -4.05 | -2.41 | -0.591 | -0.356 | -0.282 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.51 | -3.47 | -0.591 | -0.356 | -0.282 |
Net Income After Taxes | -4.51 | -3.47 | -0.591 | -0.356 | -0.282 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.51 | -3.47 | -0.591 | -0.356 | -0.282 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.51 | -3.47 | -0.591 | -0.356 | -0.282 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.933 | -0.606 | -0.103 | -0.056 | -0.027 |